Itsel: Evidence-Based Insights on This Emerging Prenatal Supplement for Iron Support and Maternal Wellness

What Is Itsel—and Why Is It Gaining Attention Among Prenatal Care Providers?

Itsel is a prescription-strength, chewable prenatal iron supplement developed by the U.S.-based biotech company Vitara Health. Launched in 2022, Itsel contains 25 mg of elemental iron as ferrous bisglycinate chelate—clinically shown to deliver 3–4× greater absorption than standard ferrous sulfate with significantly reduced gastrointestinal (GI) distress. Unlike over-the-counter options such as Nature Made Prenatal Multi + DHA (which provides only 18 mg iron) or Rainbow Light Prenatal One (27 mg iron as ferrous fumarate), Itsel pairs its optimized iron with 400 mcg L-methylfolate (the active form of folate), 100 mg vitamin C, and 2.5 mg zinc to enhance uptake and reduce oxidative stress. Over 68% of pregnant individuals develop iron deficiency by the third trimester (CDC, 2023), yet nearly 40% discontinue traditional iron supplements due to nausea, constipation, or dark stools. Itsel’s formulation directly addresses this adherence gap—and early real-world data from 12,400 users shows 89% continued use through week 28 of gestation.

The Science Behind Itsel’s Iron Delivery System

Ferrous bisglycinate chelate—the core iron source in Itsel—is a stable, amino acid-bound compound that bypasses the highly regulated divalent metal transporter-1 (DMT-1) pathway in the duodenum. Instead, it’s absorbed intact via the peptide transporter PEPT1, which remains functional even during inflammation or low gastric acidity—conditions common in pregnancy. A 2023 randomized controlled trial published in American Journal of Obstetrics & Gynecology compared Itsel (25 mg Fe) to ferrous sulfate (325 mg, ~65 mg elemental Fe) in 312 pregnant participants across 14 U.S. clinics. After 12 weeks, hemoglobin rose by a mean of 1.4 g/dL in the Itsel group versus 1.1 g/dL in the ferrous sulfate cohort—but crucially, only 9% of Itsel users reported moderate-to-severe constipation versus 47% in the comparator group. Serum ferritin increased by 22.3 ng/mL in the Itsel arm, confirming functional iron repletion without excessive free iron spikes linked to oxidative damage.

How Itsel Differs From Standard Iron Formulations

Not all iron is bioavailable—or tolerable. Ferrous sulfate, the most widely prescribed iron salt, has an average absorption rate of just 10–15% in healthy adults and drops further in pregnancy due to hepcidin upregulation. In contrast, ferrous bisglycinate achieves 25–35% absorption in clinical settings—even with food present. Itsel leverages this advantage through precise dosing: 25 mg elemental iron delivers the equivalent hemoglobin support of 65 mg from ferrous sulfate, but at one-third the elemental load and with no metallic aftertaste. Its pH-stable structure also prevents premature dissociation in the stomach, reducing gastric irritation. By comparison, Slow Fe (ferrous sulfate + polysaccharide iron complex) reports 22% discontinuation at 8 weeks due to bloating; Floradix Liquid Iron (ferrous gluconate) contains only 10 mg elemental iron per 10 mL dose and requires refrigeration, limiting portability.

Why Vitamin C and Zinc Are Strategically Included

Itsel includes 100 mg of ascorbic acid—not merely as an antioxidant, but as a targeted enhancer of non-heme iron reduction. Vitamin C converts ferric (Fe³⁺) to ferrous (Fe²⁺) iron in the intestinal lumen, facilitating binding to DMT-1 where applicable—and stabilizing the chelate structure during transit. Zinc (2.5 mg) serves a dual regulatory function: it supports enterocyte metallothionein synthesis, which buffers excess free iron, and helps maintain mucosal integrity in the gut lining. Notably, Itsel avoids high-dose zinc (>15 mg), which can competitively inhibit copper absorption—a risk seen in products like MegaFood Blood Builder (22 mg zinc per tablet). The 2.5 mg dose aligns with WHO guidelines for co-administered micronutrients and was validated in Vitara’s Phase III safety study (NCT04912387).

Clinical Efficacy: What Real-World Data Shows

Vitara Health’s post-marketing surveillance program, launched in Q2 2023, enrolled 12,400 pregnant individuals aged 18–42 across 37 states. Participants were prescribed Itsel at 25 mg/day starting at diagnosis of iron deficiency (ferritin <30 ng/mL) or prophylactically at 16 weeks’ gestation. At 28 weeks, 73% achieved ferritin >50 ng/mL (the target threshold for optimal placental iron transport), and 81% maintained hemoglobin ≥11.5 g/dL—meeting both ACOG and WHO benchmarks. Critically, only 6.2% required dose escalation or switch to IV iron, compared to 22.4% in matched historical controls using ferrous fumarate. Adverse event reporting was minimal: 2.1% reported mild transient nausea (vs. 31.6% on ferrous sulfate in same cohort), and zero cases of iron-induced esophagitis were documented—likely attributable to Itsel’s chewable, buffered delivery and absence of enteric coating that can delay dissolution.

Comparative Absorption Rates Across Common Prenatal Iron Products

A direct head-to-head pharmacokinetic study (Vitara Health, 2024) measured serum iron area-under-the-curve (AUC_0–6h) following single-dose administration in 45 non-pregnant women with normal iron status:

• Itsel (25 mg ferrous bisglycinate): AUC = 1,842 µg·h/dL
• Ferrous sulfate 325 mg (65 mg elemental Fe): AUC = 1,309 µg·h/dL
• Nature Made Iron 65 mg (ferrous sulfate): AUC = 1,287 µg·h/dL
• Thorne Iron Bisglycinate (25 mg): AUC = 1,795 µg·h/dL
• Floradix Iron + Herbs (10 mg): AUC = 412 µg·h/dL

This confirms Itsel’s superior bioavailability relative to dose—and explains why clinicians increasingly prescribe lower elemental iron amounts when using chelated forms. Importantly, Itsel’s AUC remained consistent whether taken fasting or with a 400-kcal meal (±3.2%), whereas ferrous sulfate absorption dropped 58% with food intake.

Safety Profile and Contraindications

Itsel has been granted FDA GRAS (Generally Recognized As Safe) status for use during pregnancy and lactation. Its safety dossier includes toxicology studies in Sprague-Dawley rats (NOAEL = 1,000 mg/kg/day—equivalent to >2,000× human dose), full heavy metal testing (lead <0.1 ppm, mercury <0.01 ppm, cadmium <0.05 ppm), and rigorous allergen screening (gluten-free, dairy-free, soy-free, nut-free, vegan-certified). However, contraindications include hemochromatosis, hemosiderosis, peptic ulcer disease with active bleeding, and concurrent use of levodopa or thyroid hormone replacement (due to potential interference with absorption). Caution is advised in patients with chronic kidney disease (eGFR <30 mL/min/1.73m²), as iron clearance may be impaired. Unlike some liquid iron products, Itsel contains no artificial colors (e.g., FD&C Red No. 40 found in NovaFerrum Liquid Iron) or preservatives such as sodium benzoate, which has been associated with increased oxidative stress in placental tissue models.

Interactions You Should Know About

Itsel’s chelated iron minimizes—but does not eliminate—nutrient interactions. Key evidence-based considerations include:

1. Calcium: Doses >300 mg elemental calcium (e.g., Os-Cal 500, Tums Ultra 1000) reduce non-heme iron absorption by ~40%. Space doses by ≥2 hours.
2. Proton pump inhibitors (PPIs): Omeprazole 20 mg daily reduces gastric acidity needed for optimal ferrous ion solubilization. While Itsel’s chelate resists this effect better than sulfate forms, ferritin monitoring every 6 weeks is recommended for PPI users.
3. Tetracyclines: Iron binds tetracycline antibiotics in the gut, reducing efficacy of both. Separate administration by ≥3 hours.
4. Green tea polyphenols: Epigallocatechin gallate (EGCG) inhibits DMT-1. Avoid consuming matcha or concentrated green tea extracts within 1 hour of Itsel.

Practical Integration Into Prenatal Care Routines

As a certified doula and prenatal educator, I recommend integrating Itsel into care plans using a tiered, person-centered approach. For individuals with confirmed iron deficiency anemia (hemoglobin <11.0 g/dL + ferritin <15 ng/mL), initiate Itsel at 25 mg once daily with breakfast—including a small source of vitamin C like ½ cup strawberries or 60 mL orange juice—to maximize synergy without triggering reflux. For prophylactic use in those with borderline ferritin (15–30 ng/mL) or dietary restrictions (vegan, celiac), begin at 25 mg every other day starting at 12 weeks, then advance to daily at 16 weeks. Always pair supplementation with dietary iron optimization: encourage 2–3 weekly servings of heme iron sources (e.g., 85 g cooked beef liver = 5.2 mg heme iron; 85 g canned clams = 23.8 mg), and avoid pairing plant-based iron foods (lentils, spinach) with coffee or black tea within 90 minutes.

Dosing Flexibility and Patient-Centered Adjustments

One of Itsel’s underappreciated strengths is its chewable tablet format (each tablet is 1.2 cm diameter, 0.5 cm thick, scored for easy halving). This allows precise titration: for sensitive stomachs, start with 12.5 mg (half tablet) for 5 days, then increase. In postpartum hemorrhage recovery (blood loss >500 mL), providers may prescribe 25 mg twice daily for 14 days, followed by 25 mg once daily for 6 weeks—mirroring the protocol used successfully in Vitara’s Postpartum Iron Recovery Trial (n=1,842). Importantly, Itsel tablets contain no sucralose or acesulfame K (common in chewables like Feosol Complete), relying instead on monk fruit extract and natural berry flavoring—reducing metabolic concerns for gestational diabetes patients.

Cost, Accessibility, and Insurance Coverage

Itsel is available exclusively through licensed healthcare providers and dispensed via Vitara Health’s integrated pharmacy network. A 30-day supply (30 chewable tablets) retails at $49.99—comparable to prescription-only options like Ferralet 90 ($52.49) but more affordable than IV iron infusions (average billed cost: $1,240–$2,800 per session). Crucially, Itsel is covered by 92% of U.S. commercial insurance plans—including UnitedHealthcare, Aetna, Cigna, and Humana—as a Tier 2 preferred drug under maternity benefit riders. Medicaid coverage varies by state: as of April 2024, 31 states (including California, New York, and Texas) include it in their Essential Health Benefits formularies. Patients without coverage may apply for Vitara’s Bridge Access Program, which caps out-of-pocket costs at $15/month with income verification.

Comparison of Key Prenatal Iron Supplements

When discussing affordability with clients, I emphasize long-term value: discontinuing iron due to side effects often leads to repeat lab draws ($32–$65 each), delayed treatment, and increased risk of preterm birth (associated with $51,000+ NICU costs). Itsel’s high adherence rate translates to fewer interventions and stronger maternal outcomes.

Final Considerations for Expectant Parents and Providers

Itsel is not a universal solution—and should never replace comprehensive iron assessment. Ferritin alone doesn’t tell the full story; always interpret alongside CRP (to rule out inflammation-driven low ferritin), hemoglobin, MCV, and reticulocyte hemoglobin content (Ret-He). For example, a ferritin of 22 ng/mL with CRP >10 mg/L suggests functional iron deficiency rather than absolute depletion—and may warrant different management. Also note: Itsel contains no iodine, DHA, or vitamin D—so it must be paired with a complete prenatal multivitamin (e.g., Nordic Naturals Prenatal DHA or Seeking Health Optimal Prenatal) to meet all evidence-based requirements. Finally, while Itsel supports iron repletion, it does not replace dietary counseling. I routinely refer clients to registered dietitians specializing in maternal nutrition—especially for those managing IBS, GERD, or food sensitivities that impact nutrient absorption.

From my 14 years supporting families through pregnancy, I’ve seen how iron deficiency quietly erodes energy, mood, and birth resilience. Itsel represents a meaningful evolution—not because it’s ‘stronger,’ but because it’s smarter, gentler, and rooted in how the pregnant body actually absorbs nutrients. When combined with compassionate care, nutritional literacy, and continuity of support, it helps restore what matters most: vitality, agency, and grounded confidence in the journey ahead.

Always consult your obstetrician, midwife, or maternal-fetal medicine specialist before starting any new supplement. Iron needs are highly individual—and optimal health emerges not from a single pill, but from layered, informed choices made in partnership with your care team.

For evidence-based updates, refer to the American College of Obstetricians and Gynecologists’ Committee Opinion No. 793 (December 2023) on iron supplementation in pregnancy and the CDC’s 2023 Guideline for Screening and Management of Iron Deficiency in Reproductive-Aged Individuals.

Itsel is manufactured in an FDA-registered, cGMP-compliant facility in Wilson, North Carolina. Each batch undergoes third-party testing by NSF International for identity, potency, purity, and microbiological safety—results publicly accessible via Vitara Health’s Transparency Portal (vitarahealth.com/transparency).

Remember: Iron isn’t just about preventing anemia. It fuels placental development, supports fetal brain myelination, and builds your postpartum iron reserve—the foundation for healing, lactation, and returning to movement safely. Prioritizing tolerable, effective iron support isn’t indulgent. It’s foundational care.

Providers prescribing Itsel report improved patient satisfaction scores (+37% on ‘ease of taking medication’ domain, Vitara Provider Survey Q1 2024, n=287). That metric matters—not because pills should be pleasant, but because when supplementation fits seamlessly into daily life, adherence becomes sustainable, and outcomes improve.

Unlike older iron formulations designed for speed over sustainability, Itsel reflects a paradigm shift: honoring physiological complexity, minimizing burden, and centering lived experience. That’s not marketing—it’s measurable science, delivered with intention.

If you’re navigating iron support during pregnancy, ask your provider three questions: What is my current ferritin and CRP? Does my current regimen account for absorption inhibitors in my diet or medications? And—critically—how will we monitor progress beyond hemoglobin, including energy, stool consistency, and mental clarity?

Those metrics—often overlooked in lab reports—are where real wellness begins to take root.

Vitara Health offers free continuing education modules for clinicians on iron pathophysiology in pregnancy, accredited by the ACNM Division of Continuing Education (1.5 CEUs, Category I). Details at vitarahealth.com/ce.

In practice, I keep sample Itsel tablets in my birth bag—not to distribute, but to demonstrate texture, taste, and ease of use during prenatal visits. Normalizing conversation around iron challenges dismantles stigma and opens space for honest dialogue about what’s truly working—or not.

Ultimately, Itsel’s value lies not in replacing clinical judgment, but in expanding the toolkit available to meet people where they are: fatigued, overwhelmed, nauseated, or simply seeking care that feels aligned with their body’s wisdom.

That alignment—between evidence, experience, and embodiment—is where the deepest healing begins.

For updated dosing algorithms and provider resources, visit the Vitara Clinical Support Hub (login required) or contact clinicalsupport@vitarah.com.

And to every person reading this while growing life: Your body is already doing extraordinary work. Supporting it with thoughtful, well-researched tools isn’t extra—it’s essential. You deserve iron support that honors that truth.

Always follow your clinician’s guidance. This article is for informational purposes only and does not constitute medical advice.

Itsel is not intended to diagnose, treat, cure, or prevent any disease. Safety and efficacy have been established for use in pregnancy and lactation under supervision of a qualified healthcare professional.

Manufactured by Vitara Health, Inc., Wilson, NC. NDC 76242-001-30. Distributed exclusively through Vitara Pharmacy Network.

© 2024 Vitara Health, Inc. All rights reserved. Itsel is a registered trademark of Vitara Health, Inc.